Eva Yin

Ms. Eva Yin is currently Chief Commercial Officer, BeiGene Greater China. Eva possesses nearly 20 years of experience in the pharmaceutical industry, having held various positions in finance, compliance, commercial & diversified channels, from where she gains profound insights into the development and characteristics of the healthcare industry.

Prior to BeiGene, Ms. Yin worked at AstraZeneca from 2006 to 2021; She held various positions including Senior Business Finance Manager, Area Strategy Project Lead for International markets, China & HK Compliance VP, Commercial & Diversified Channel VP. By Jan 2017, Eva expanded her responsibility to oversight AZ HK & Macau. Since Jun 2018, Eva had been appointed as AstraZeneca China Vice President, Oncology, and been promoted as General Manager of Oncology, AstraZeneca China by Jan 2019.

Eva graduated from Shanghai Jiao Tong University, majoring in Finance & Trading and Computer Science. She obtained her full-time MBA from CEIBS (China Europe International Business School) and completed the exchange program in LBS (London Business School) in 2002.